Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis
From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no...
Gespeichert in:
Veröffentlicht in: | Medicine (Baltimore) 2014-12, Vol.93 (27), p.e137-e137 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e137 |
---|---|
container_issue | 27 |
container_start_page | e137 |
container_title | Medicine (Baltimore) |
container_volume | 93 |
creator | Ortiz, Carlos López, Javier García, Héctor Sevilla, Teresa Revilla, Ana Vilacosta, Isidre Sarriá, Cristina Olmos, Carmen Ferrera, Carlos García, Pablo Elpidio Sáez, Carmen Gómez, Itziar San Román, José Alberto |
description | From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them. |
doi_str_mv | 10.1097/MD.0000000000000137 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4602814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1637549772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</originalsourceid><addsrcrecordid>eNpdkU1vFDEMhiMEotvCL0BCc-QyJcnkY-eChLYfrNQKBOUceRNnN5BNSpJtxb9n2i1VwRdb9uPXll5C3jB6zOio31-eHNOnwQb9jMyYHFQvRyWekxmlXPZ61OKAHNb64x7h4iU54FJSRiWfkatFDClYiN0iQq3BT3ULOXWQXPel5HXKNdQu-25Zc4SGrvsa1pvWfwtuqpfJo23hBrvT5LKF4kIL9RV54SFWfP2Qj8j3s9Orxaf-4vP5cvHxordCUtVzhTjn1DsAiyvpPJfgGUfBQa80MnCj1NLauVoNHIGOjgsLXoJk1oPSwxH5sNe93q226CymViCa6xK2UH6bDMH8O0lhY9b5xghF-ZyJSeDdg0DJv3ZYm9mGajFGSJh31TA1aClGrfmEDnvUllxrQf94hlFz54e5PDH_-zFtvX364ePOXwMmQOyB2xwblvoz7m6xmA1CbJt7PalH3nPKBOOU0_6upYY_v9OXog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1637549772</pqid></control><display><type>article</type><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</creator><creatorcontrib>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</creatorcontrib><description>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000000137</identifier><identifier>PMID: 25501052</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Defibrillators, Implantable - microbiology ; Drug Users - statistics & numerical data ; Echocardiography ; Endocarditis - diagnostic imaging ; Endocarditis - epidemiology ; Endocarditis - microbiology ; Female ; Humans ; Male ; Middle Aged ; Observational Study ; Pacemaker, Artificial - microbiology ; Prognosis ; Spain - epidemiology ; Tertiary Care Centers</subject><ispartof>Medicine (Baltimore), 2014-12, Vol.93 (27), p.e137-e137</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><rights>Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</citedby><cites>FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602814/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602814/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25501052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ortiz, Carlos</creatorcontrib><creatorcontrib>López, Javier</creatorcontrib><creatorcontrib>García, Héctor</creatorcontrib><creatorcontrib>Sevilla, Teresa</creatorcontrib><creatorcontrib>Revilla, Ana</creatorcontrib><creatorcontrib>Vilacosta, Isidre</creatorcontrib><creatorcontrib>Sarriá, Cristina</creatorcontrib><creatorcontrib>Olmos, Carmen</creatorcontrib><creatorcontrib>Ferrera, Carlos</creatorcontrib><creatorcontrib>García, Pablo Elpidio</creatorcontrib><creatorcontrib>Sáez, Carmen</creatorcontrib><creatorcontrib>Gómez, Itziar</creatorcontrib><creatorcontrib>San Román, José Alberto</creatorcontrib><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Defibrillators, Implantable - microbiology</subject><subject>Drug Users - statistics & numerical data</subject><subject>Echocardiography</subject><subject>Endocarditis - diagnostic imaging</subject><subject>Endocarditis - epidemiology</subject><subject>Endocarditis - microbiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Pacemaker, Artificial - microbiology</subject><subject>Prognosis</subject><subject>Spain - epidemiology</subject><subject>Tertiary Care Centers</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1vFDEMhiMEotvCL0BCc-QyJcnkY-eChLYfrNQKBOUceRNnN5BNSpJtxb9n2i1VwRdb9uPXll5C3jB6zOio31-eHNOnwQb9jMyYHFQvRyWekxmlXPZ61OKAHNb64x7h4iU54FJSRiWfkatFDClYiN0iQq3BT3ULOXWQXPel5HXKNdQu-25Zc4SGrvsa1pvWfwtuqpfJo23hBrvT5LKF4kIL9RV54SFWfP2Qj8j3s9Orxaf-4vP5cvHxordCUtVzhTjn1DsAiyvpPJfgGUfBQa80MnCj1NLauVoNHIGOjgsLXoJk1oPSwxH5sNe93q226CymViCa6xK2UH6bDMH8O0lhY9b5xghF-ZyJSeDdg0DJv3ZYm9mGajFGSJh31TA1aClGrfmEDnvUllxrQf94hlFz54e5PDH_-zFtvX364ePOXwMmQOyB2xwblvoz7m6xmA1CbJt7PalH3nPKBOOU0_6upYY_v9OXog</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Ortiz, Carlos</creator><creator>López, Javier</creator><creator>García, Héctor</creator><creator>Sevilla, Teresa</creator><creator>Revilla, Ana</creator><creator>Vilacosta, Isidre</creator><creator>Sarriá, Cristina</creator><creator>Olmos, Carmen</creator><creator>Ferrera, Carlos</creator><creator>García, Pablo Elpidio</creator><creator>Sáez, Carmen</creator><creator>Gómez, Itziar</creator><creator>San Román, José Alberto</creator><general>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141201</creationdate><title>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</title><author>Ortiz, Carlos ; López, Javier ; García, Héctor ; Sevilla, Teresa ; Revilla, Ana ; Vilacosta, Isidre ; Sarriá, Cristina ; Olmos, Carmen ; Ferrera, Carlos ; García, Pablo Elpidio ; Sáez, Carmen ; Gómez, Itziar ; San Román, José Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4506-26ee820fdaaceb5df25af12e42a7b7e1ad9575cc86b32ea09d24caf5a51cfa673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Defibrillators, Implantable - microbiology</topic><topic>Drug Users - statistics & numerical data</topic><topic>Echocardiography</topic><topic>Endocarditis - diagnostic imaging</topic><topic>Endocarditis - epidemiology</topic><topic>Endocarditis - microbiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Pacemaker, Artificial - microbiology</topic><topic>Prognosis</topic><topic>Spain - epidemiology</topic><topic>Tertiary Care Centers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ortiz, Carlos</creatorcontrib><creatorcontrib>López, Javier</creatorcontrib><creatorcontrib>García, Héctor</creatorcontrib><creatorcontrib>Sevilla, Teresa</creatorcontrib><creatorcontrib>Revilla, Ana</creatorcontrib><creatorcontrib>Vilacosta, Isidre</creatorcontrib><creatorcontrib>Sarriá, Cristina</creatorcontrib><creatorcontrib>Olmos, Carmen</creatorcontrib><creatorcontrib>Ferrera, Carlos</creatorcontrib><creatorcontrib>García, Pablo Elpidio</creatorcontrib><creatorcontrib>Sáez, Carmen</creatorcontrib><creatorcontrib>Gómez, Itziar</creatorcontrib><creatorcontrib>San Román, José Alberto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ortiz, Carlos</au><au>López, Javier</au><au>García, Héctor</au><au>Sevilla, Teresa</au><au>Revilla, Ana</au><au>Vilacosta, Isidre</au><au>Sarriá, Cristina</au><au>Olmos, Carmen</au><au>Ferrera, Carlos</au><au>García, Pablo Elpidio</au><au>Sáez, Carmen</au><au>Gómez, Itziar</au><au>San Román, José Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>93</volume><issue>27</issue><spage>e137</spage><epage>e137</epage><pages>e137-e137</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>From an epidemiologic point of view, right-sided infective endocarditis (RSIE) affects different types of patients: intravenous drug users (IDUs), cardiac device carriers (pacemakers and implantable automatic defibrillators), and the "3 noes" endocarditis group: no left-sided, no IDUs, no cardiac devices. Our objective is to describe and compare the clinical profile and outcome of these groups of patients. Every episode of infective endocarditis (IE) consecutively diagnosed in 3 tertiary centers from 1996 to 2012 was included in an ongoing multipurpose database. We assessed 85 epidemiologic, clinical, echocardiographic, and outcome variables in patients with isolated RSIE. A bivariated comparative analysis between the 3 groups was conducted.Among 866 IE episodes, 121 were classified as isolated RSIE (14%): 36 IDUs (30%), 65 cardiac device carriers (54%), and 20 "3 noes" group (16%). IDUs were mainly young men (36 ± 7 years) without previous heart disease, few comorbidities, and frequent previous endocarditis episodes (28%). Human immunodeficiency virus infection was frequent (69%). Cardiac device carriers were older (66 ± 15 years) and had less comorbidities (34%). Removal of the infected device was performed in 91% of the patients without any death. The "3 noes" endocarditis group was composed mainly by middle-age men (56 ± 18 years), health care related infections (50%), and had many comorbidities (75%). Whereas Staphylococcus aureus were the most frequent cause in IDUs (72% vs 34% in device carriers and 34% in the "3 noes" group, P = 0.001), coagulase negative Staphylococci predominated in the device carriers (58% vs 11% in drug users and 35% in the "3 noes", P < 0.001). Significant differences in mortality were found (17% in drug users, 3% in device carriers, and 30% in the "3 noes" group; P < 0.001). These results suggest that RSIE should be separated into 3 groups (IDUs, cardiac device carriers, and the "3 noes") and considered as independent entities as there are relevant epidemiologic, clinical, microbiological, echocardiographic, and prognostic differences among them.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>25501052</pmid><doi>10.1097/MD.0000000000000137</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7974 |
ispartof | Medicine (Baltimore), 2014-12, Vol.93 (27), p.e137-e137 |
issn | 0025-7974 1536-5964 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4602814 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over Defibrillators, Implantable - microbiology Drug Users - statistics & numerical data Echocardiography Endocarditis - diagnostic imaging Endocarditis - epidemiology Endocarditis - microbiology Female Humans Male Middle Aged Observational Study Pacemaker, Artificial - microbiology Prognosis Spain - epidemiology Tertiary Care Centers |
title | Clinical Classification and Prognosis of Isolated Right-Sided Infective Endocarditis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A24%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Classification%20and%20Prognosis%20of%20Isolated%20Right-Sided%20Infective%20Endocarditis&rft.jtitle=Medicine%20(Baltimore)&rft.au=Ortiz,%20Carlos&rft.date=2014-12-01&rft.volume=93&rft.issue=27&rft.spage=e137&rft.epage=e137&rft.pages=e137-e137&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000000137&rft_dat=%3Cproquest_pubme%3E1637549772%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1637549772&rft_id=info:pmid/25501052&rfr_iscdi=true |